$INIS
INTERNATIONAL ISOTOPES INC Stock $inis

$inis Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000143774923031604 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3
Revenue	$3.147M	$2.919M
YoY Change	-0.11%	4.64%
Cost Of Revenue	$1.183M	$1.126M
YoY Change	-16.73%	-13.77%
Gross Profit	$1.964M	$1.793M
YoY Change	13.56%	20.84%
Gross Profit Margin	62.4%	61.42%
Selling, General & Admin	$1.885M	$2.000M
YoY Change	15.01%	10.57%
% of Gross Profit	96.0%	111.57%
Research & Development	$169.3K	$100.5K
YoY Change	85.42%	-32.21%
% of Gross Profit	8.62%	5.61%
Depreciation & Amortization	$90.09K	$86.63K
YoY Change	4.57%	2.53%
% of Gross Profit	4.59%	4.83%
Operating Expenses	$2.054M	$2.102M
YoY Change	18.73%	7.41%
Operating Profit	-$90.81K	-$309.5K
YoY Change	7531.09%	-34.65%
Interest Expense	-$54.62K	$82.35K
YoY Change	-61.74%	-44.03%
% of Operating Profit
Other Income/Expense, Net	$36.37K	-$39.15K
YoY Change	10.68%	-58.84%
Pretax Income	-$109.1K	-$350.0K
YoY Change	-1.83%	-38.45%
Income Tax
% Of Pretax Income
Net Earnings	-$109.1K	-$348.6K
YoY Change	-1.83%	-38.7%
Net Earnings / Revenue	-3.47%	-11.94%
Basic Earnings Per Share		$0.00
Diluted Earnings Per Share	$0.00	$0.00
COMMON SHARES
Basic Shares Outstanding	519.8M	518.0M
Diluted Shares Outstanding		518.3M

Balance Sheet

Concept	2023 Q4	2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.688M	$2.900M
YoY Change	13.15%	-2.99%
Cash & Equivalents	$2.688M	$2.897M
Short-Term Investments
Other Short-Term Assets	$672.9K	$440.0K
YoY Change	-34.23%	-50.65%
Inventory	$927.1K	$740.8K
Prepaid Expenses
Receivables	$1.469M	$1.383M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$5.757M	$5.458M
YoY Change	0.29%	-13.4%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.656M	$2.455M
YoY Change	129.97%	22.06%
Goodwill	$1.384M	$1.384M
YoY Change	0.0%	0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$1.569M	$1.080M
YoY Change	46.91%	1.22%
Total Long-Term Assets	$11.15M	$10.73M
YoY Change	6.13%	1.56%
TOTAL ASSETS
Total Short-Term Assets	$5.757M	$5.458M
Total Long-Term Assets	$11.15M	$10.73M
Total Assets	$16.91M	$16.19M
YoY Change	4.07%	-4.03%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$559.6K	$281.7K
YoY Change	46.34%	-76.15%
Accrued Expenses	$1.623M	$1.342M
YoY Change	10.21%	9.07%
Deferred Revenue	$932.7K
YoY Change	6.06%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$158.6K	$780.0K
YoY Change	579.16%	2051.55%
Total Short-Term Liabilities	$3.274M	$3.545M
YoY Change	-6.86%	-58.25%
LONG-TERM LIABILITIES
Long-Term Debt	$5.954M	$5.370M
YoY Change	16.73%	712.92%
Other Long-Term Liabilities	$3.641M	$3.190M
YoY Change	10.76%	-3.84%
Total Long-Term Liabilities	$9.595M	$8.561M
YoY Change	14.39%	115.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.274M	$3.545M
Total Long-Term Liabilities	$9.595M	$8.561M
Total Liabilities	$12.87M	$12.11M
YoY Change	8.12%	-2.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$127.3M	-$127.2M
YoY Change	0.69%	0.69%
Common Stock	$5.198M	$5.198M
YoY Change	0.95%	0.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.037M	$4.079M
YoY Change
Total Liabilities & Shareholders Equity	$16.91M	$16.19M
YoY Change	4.07%	-4.03%

Cashflow Statement

Concept	2023 Q4	2023 Q3
OPERATING ACTIVITIES
Net Income	-$109.1K	-$348.6K
YoY Change	-1.83%	-38.7%
Depreciation, Depletion And Amortization	$90.09K	$86.63K
YoY Change	4.57%	2.53%
Cash From Operating Activities	-$117.4K	-$300.0K
YoY Change	-78.28%	4809.98%
INVESTING ACTIVITIES
Capital Expenditures	-$400.9K	$480.0K
YoY Change	-875.06%	-3769.72%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	$400.9K	-$480.0K
YoY Change	-874.91%	3572.53%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-480.5K	420.0K
YoY Change	3052.89%	-3037.06%
NET CHANGE
Cash From Operating Activities	-117.4K	-300.0K
Cash From Investing Activities	400.9K	-480.0K
Cash From Financing Activities	-480.5K	420.0K
Net Change In Cash	-197.0K	-360.0K
YoY Change	-67.58%	975.27%
FREE CASH FLOW
Cash From Operating Activities	-$117.4K	-$300.0K
Capital Expenditures	-$400.9K	$480.0K
Free Cash Flow	$283.5K	-$780.0K
YoY Change	-147.87%	-11290.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	750000000
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	519750538
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	519750538
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	514889916
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	514889916
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	pure
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	pure
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	0-22923
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	TX
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	74-2763837
	dei	Entity Address Address Line1 EntityAddressAddressLine1	4137 Commerce Circle
	dei	Entity Address City Or Town EntityAddressCityOrTown	Idaho Falls
	dei	Entity Address State Or Province EntityAddressStateOrProvince	ID
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	83401
	dei	City Area Code CityAreaCode	208
	dei	Local Phone Number LocalPhoneNumber	524-5300
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	519787870
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2897208	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2375817	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1382701	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1596886	usd
CY2023Q3	us-gaap	Inventory Net InventoryNet	740803	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	744793	usd
CY2023Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	437354	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1023129	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	5458066	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	5740625	usd
CY2023Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	869339	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	840049	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2455232	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2024486	usd
CY2023Q3	inis	Capitalized Lease Disposal Costs Net CapitalizedLeaseDisposalCostsNet	214158	usd
CY2022Q4	inis	Capitalized Lease Disposal Costs Net CapitalizedLeaseDisposalCostsNet	228125	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	8114	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	12621	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2216596	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2311082	usd
CY2023Q3	us-gaap	Goodwill Goodwill	1384255	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1384255	usd
CY2023Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3579682	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	3703353	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	10727376	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	10503971	usd
CY2023Q3	us-gaap	Assets Assets	16185442	usd
CY2022Q4	us-gaap	Assets Assets	16244596	usd
CY2023Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	281715	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	382392	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1341833	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1472504	usd
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1004867	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	879365	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	138384	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	131572	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3047	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	5513	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	3545422	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3514694	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	84375	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Noncurrent AccountsPayableAndAccruedLiabilitiesNoncurrent	112500	usd
CY2023Q3	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	981948	usd
CY2022Q4	us-gaap	Asset Retirement Obligations Noncurrent AssetRetirementObligationsNoncurrent	942378	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	528	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	2832	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2127587	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2232244	usd
CY2023Q3	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent	4063000	usd
CY2022Q4	us-gaap	Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent	4063000	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8560925	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	8387360	usd
CY2023Q3	us-gaap	Liabilities Liabilities	12106347	usd
CY2022Q4	us-gaap	Liabilities Liabilities	11902054	usd
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	5197505	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	5148899	usd
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	126102394	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	125654486	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-127220804	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-126460843	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	4079095	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4342542	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16185442	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	16244596	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2918556	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2789273	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9120256	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8031522	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1125888	usd
CY2022Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1305730	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3704939	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	3470706	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	1792668	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	1483543	usd
	us-gaap	Gross Profit GrossProfit	5415317	usd
	us-gaap	Gross Profit GrossProfit	4560816	usd
CY2023Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	1152987	usd
CY2022Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	800550	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3072348	usd
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	2535771	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	848597	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1008219	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2620449	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2784367	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	100544	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	148327	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	408012	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	442383	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2102128	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1957096	usd
	us-gaap	Operating Expenses OperatingExpenses	6100809	usd
	us-gaap	Operating Expenses OperatingExpenses	5762521	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-309460	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-473553	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-685492	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1201705	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	22873	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	49151	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	123803	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	2077719	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	20328	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	2849	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	49270	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	3574	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	82346	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	147116	usd
	us-gaap	Interest Expense InterestExpense	247542	usd
	us-gaap	Interest Expense InterestExpense	465260	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-39145	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-95116	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-74469	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1616033	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-348605	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-568669	usd
	us-gaap	Net Income Loss NetIncomeLoss	-759961	usd
	us-gaap	Net Income Loss NetIncomeLoss	414328	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	518301657
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	514789680
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	517265031
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	509587202
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	518301657
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	514789680
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	517265031
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	511057330
	us-gaap	Net Income Loss NetIncomeLoss	-759961	usd
	us-gaap	Net Income Loss NetIncomeLoss	414328	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	262029	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	288047	usd
	inis	Accretion Of Obligation For Lease Disposal Costs AccretionOfObligationForLeaseDisposalCosts	39570	usd
	inis	Accretion Of Obligation For Lease Disposal Costs AccretionOfObligationForLeaseDisposalCosts	37459	usd
	us-gaap	Accretion Expense AccretionExpense	0	usd
	us-gaap	Accretion Expense AccretionExpense	210377	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	398727	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	297243	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-0	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	1797978	usd
	inis	Rightofuse Asset Amortization RightofuseAssetAmortization	3359	usd
	inis	Rightofuse Asset Amortization RightofuseAssetAmortization	1409	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-214185	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	689036	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3990	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-45565	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-585775	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-112742	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-168813	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	124609	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	125502	usd
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	890	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	697645	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-957163	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	4000000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	550629	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	68275	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-550629	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	3931725	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	7127	usd
	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	74105	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	4770	usd
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	6332	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	452100	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	50792	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	524532	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	403665	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-456759	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	550681	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	2517803	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3215866	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1305603	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3766547	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3823406	usd
	us-gaap	Interest Paid Net InterestPaidNet	159926	usd
	us-gaap	Interest Paid Net InterestPaidNet	49699	usd
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	90660	usd
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	204480	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	675000	usd
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2897208	usd
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2989236	usd
CY2023Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	869339	usd
CY2022Q3	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	834170	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3766547	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3823406	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4342542	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	7127	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	0	usd
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	90660	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	398727	usd
	us-gaap	Net Income Loss NetIncomeLoss	-759961	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	4079095	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	4251572	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2247	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	173881	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-348605	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	4079095	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	2730795	usd
	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	12305	usd
	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	0	usd
	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	204480	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
	inis	Stock Issued During Period Value Warrant Exercises StockIssuedDuringPeriodValueWarrantExercises	61800	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	675000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	297243	usd
	us-gaap	Net Income Loss NetIncomeLoss	414328	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	4395951	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	4901719	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	3132	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	0	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	59769	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-568669	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	4395951	usd
CY2023Q3	inis	Percent Of Total Revenues PercentOfTotalRevenues	1	pure
	us-gaap	Net Income Loss NetIncomeLoss	-759961	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	697645	usd
	us-gaap	Net Income Loss NetIncomeLoss	414328	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-957163	usd
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	518301657
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	514789680
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	517265031
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	509587202
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	518301657
CY2022Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	514789680
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	517265031
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	511057330
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	26012500
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	24868500
CY2023Q3	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	73642500
CY2022Q3	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	65498500
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	24993500
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.05
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3025000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.04
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1000000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.09
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1006000
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	0.07
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	26012500
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.05
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y9M18D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	17000	usd
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	19582500
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	0.05
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y10M24D
CY2023Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	15750	usd
CY2023Q3	us-gaap	Share Price SharePrice	0.04
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	129446	usd
CY2023Q1	us-gaap	Share Price SharePrice	0.04
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1000000
CY2023Q3	us-gaap	Share Price SharePrice	0.06
CY2014Q4	inis	Other Commitments Annual Fixed Price Escalation Percent OtherCommitmentsAnnualFixedPriceEscalationPercent	0.05	pure
CY2023Q3	us-gaap	Restricted Cash And Investments RestrictedCashAndInvestments	869339	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2918556	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	799	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2789273	usd
CY2022Q3	inis	Percent Of Total Revenues PercentOfTotalRevenues	1	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9120256	usd
	inis	Percent Of Total Revenues PercentOfTotalRevenues	1	pure
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8031522	usd
	inis	Percent Of Total Revenues PercentOfTotalRevenues	1	pure
CY2023Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	1004867	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	879365	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1382701	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1596886	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	215331	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	213382	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	5400	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	7996	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	5281	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	6331	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	339	usd
	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	899	usd
	inis	Finance Lease Expense FinanceLeaseExpense	5620	usd
	inis	Finance Lease Expense FinanceLeaseExpense	7230	usd
	us-gaap	Lease Cost LeaseCost	226351	usd
	us-gaap	Lease Cost LeaseCost	228608	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	usd
CY2023Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y3M18D
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y3M18D
CY2023Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y2M12D
CY2022Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y7M6D
CY2023Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0675	pure
CY2022Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0675	pure
CY2023Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0675	pure
CY2022Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0822	pure
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	71777	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	287108	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	2929	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	287108	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	0	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	287108	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	287108	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2023Q3	inis	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	2025192	usd
CY2023Q3	inis	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3245401	usd
CY2023Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	3728	usd
CY2023Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	979430	usd
CY2023Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	153	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	2265971	usd
CY2023Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	3575	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	138384	usd
CY2023Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	3047	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2127587	usd
CY2023Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	528	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2918556	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2789273	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	9120256	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	8031522	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	86631	usd
CY2022Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	84496	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	262029	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	288047	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-348605	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-568669	usd
	us-gaap	Net Income Loss NetIncomeLoss	-759961	usd
	us-gaap	Net Income Loss NetIncomeLoss	414328	usd
CY2023Q3	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	484107	usd
CY2022Q3	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	13075	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	550629	usd
	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	68275	usd
CY2023Q3	us-gaap	Assets Assets	16185442	usd
CY2022Q4	us-gaap	Assets Assets	16244596	usd

Files In Submission

Name	View Source	Status
inis-20230930_cal.xml	Edgar Link	unprocessable
0001437749-23-031604-index-headers.html	Edgar Link	pending
0001437749-23-031604-index.html	Edgar Link	pending
0001437749-23-031604.txt	Edgar Link	pending
0001437749-23-031604-xbrl.zip	Edgar Link	pending
ex_562283.htm	Edgar Link	pending
ex_562284.htm	Edgar Link	pending
ex_562285.htm	Edgar Link	pending
ex_562286.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
inis-20230930.xsd	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
inis20230817_10q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
inis-20230930_lab.xml	Edgar Link	unprocessable
inis-20230930_def.xml	Edgar Link	unprocessable
inis-20230930_pre.xml	Edgar Link	unprocessable
inis20230817_10q_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$INIS
INTERNATIONAL ISOTOPES INC Stock $inis

2023 Q4 Form 10-Q Financial Statement

#000143774923031604 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INIS INTERNATIONAL ISOTOPES INC Stock $inis

2023 Q4 Form 10-Q Financial Statement

#000143774923031604 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$INIS
INTERNATIONAL ISOTOPES INC Stock $inis